Skip to main content
Premium Trial:

Request an Annual Quote

Spotfire Adapts Software To Affymetrix Platform, Launches New Product

Premium

CAMBRIDGE, Mass.--Spotfire entered a deal last week to integrate its Spotfire Pro research and development decision support software with Affymetrix's GeneChip platform. The system is intended to permit life sciences researchers and bioinformatics professionals to graphically view and understand information generated with GeneChip expression monitoring arrays and stored in databases that comply with Genetic Analysis Technology Consortium (GATC) standards. The companies said that Spotfire Pro, a Windows-based application, gives laboratory scientists the power to access and manipulate information contained in GATC databases.

Spotfire also released Expression Explorer 1.0 this month, the third scientific component in the company's Spotfire Pro application. The gene expression data analysis tool is also compliant with GATC standards and can be applied to data in a standard Oracle database. The company claimed Expression Explorer enables scientists to instantly search GATC-compliant databases for gene expression data or information on selected experiments and then automatically clusters genes with similar traits or patterns of coregulation over time for closer examination.

GATC was founded in 1997 by Affymetrix and Molecular Dynamics to standardize the field of array-based genetic analysis. The consortium aims to provide a technology platform to design, process, read, and analyze genetic information from DNA arrays.

Filed under

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.